ERBB2 and breast carcinoma: A study that utilized the TCGA dataset to analyze the association between genomic alterations and immune metagene expression revealed that the higher immune gene expression and lower clonal diversity indicates the immune pruning effect in TNBC and HER2+ breast cancers [11].